ドキサントラゾール (doxantrazole) は,ヒトの口服効果のある抗アレルギー剤です
Lancet (London, England)
|May 24, 1975
まとめ
ドキサントラゾールは,動物モデルとインビトロ研究の両方で抗アレルギー効果を示しており,有毒性は観察されていません. ヒトでの経口投与は,特定のアレルゲンに対する即時型の喘息反応を成功裏に抑制しました.
科学分野:
- 薬理学 薬理学とは
- アレルギー研究 アレルギー研究
- 免疫学 免疫学とは
背景:
- 喘息は慢性呼吸器疾患で,呼吸道炎症と過敏反応が特徴です.
- 現在の抗アレルギー薬には限界があり,新しい治療薬の探求が必要である.
研究 の 目的:
- ドクサントラゾールの抗アレルギー性について調べる.
- アレルギー反応の管理におけるドクサントラゾールの有効性と安全性を評価する.
主な方法:
- 抗アレルギー作用を評価するためにラットモデルでのin-vivo研究.
- 抗アレルギーの性質を確認するために,in-vitro実験を行いました.
- 臨時型の喘息反応を有するボランティア患者を含む臨床試験.
主要な成果:
- ドキサントラゾールはラットモデルで有意な抗アレルギー特性を示した.
- イン・ビトロ研究では,抗アレルギー効果が確認されました.
- 動物に対する有意な毒性は検出されなかった.
- 200 mgの経口投与は,ヒトにおいて,特定の抗原に対する即時型の喘息反応を抑制しました.
結論:
- ドキサントラゾールは,有望な抗アレルギー特性を持っています.
- この化合物はよく耐受され,アレルギー性喘息の治療の可能性を示しています.
関連する概念動画
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...


